NCT01312324View on ClinicalTrials.gov

Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

July 31, 2015

Study Completion Date

March 31, 2016

Conditions
Locally Advanced Stage III or IV Thymic Cancer
Interventions
DRUG

neoadjuvant docetaxel/cisplatin

3 cycles of docetaxel plus cisplatin docetaxel 75mg/m2 D1 cisplatin 75mg/m2 D1 every 3 weeks

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT01312324 - Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer | Biotech Hunter | Biotech Hunter